baber/WOPTO huggingface dataset:
Patent DK-1309469-T3 (DK)
Inventor: HOUGHTON JOHN MICHAEL
IPC: B60P3/04
Filed: 2001-08-17
Granted: 2008-10-13
Abstract: Airflow means in the form of fans (80) are provided in the bulkhead (11) at the front of a transporter. These fans (80) supplement the natural airflow since they direct the airflow in the transporter in the same direction as that produced naturally by movement of the trailer. The transporter may have a plurality of levels to support livestock on different levels to increase the efficiency of transporting livestock. Each level may have a pair of fans (80) in order to provide the airflow along the level. The present invention may be incorporated within a transporter comprising an integral trailer and cab and also within a trailer which can be separated from and secured to a cab unit. The airflow means take air from within the transporter and emits the air into the external atmosphere.
Patent DK-1400808-T3 (DK)
Inventor: SAKURAI MASAAKI
IPC: G01N33/553
Filed: 2002-04-26
Granted: 2006-10-23
Abstract: When insoluble magnetic carrier particles are used in immunoassay, a method is provided which is suitable for saving labor and for treating a large number of samples within a short time while avoiding problems including difficulties in the stability of sensitized insoluble magnetic particles and in their preparation. In assaying an antigenic substance in test samples, no use is made of insoluble magnetic particles carrying an antibody specific to the said antigenic substance but insoluble magnetic carrier particles are provided in a state free from adsorbing said antibody, etc. Then the antigenic substance per se to be assayed is adsorbed on the insoluble magnetic carrier particles followed by reaction with a labeled antibody specific to the said adsorbed antigenic substance. Thus, the antigenic substance in the test sample can be efficiently assayed in a mode suitable for automation.
Patent DK-1383618-T3 (DK)
Inventor: HAMSTRA PETER
IPC: B21D26/02
Filed: 2002-05-01
Granted: 2005-11-21
Abstract: A method of forming a bottle-shaped or other contoured metal container by subjecting a hollow metal preform having a closed end to internal fluid pressure to cause the preform to expand against the wall of a die cavity defining the desired shape, and advancing a punch into the die cavity to displace and deform the closed end of the preform after expansion begins but before it is complete. The pressure-subjecting step is performed by simultaneously subjecting the preform in the die cavity to independently controllable internal and external positive fluid pressures and varying the difference between them to control strain rate.
Patent DK-1448723-T3 (DK)
Inventor: GILLARD MICHEL
IPC: C09D5/16
Filed: 2002-10-25
Granted: 2006-09-04
Abstract: Silylesters of rosin are used in self-polishing antifouling paints alone or in combination with other binder components.
Patent DK-1413268-T3 (DK)
Inventor: BOTTEN RONALD S
IPC: A61F5/443
Filed: 2003-10-23
Granted: 2009-06-29
Abstract: A convex adapter comprises an adapter ring (20) formed of a soft shape-recoverable skin barrier material. The barrier material comprises a continuous phase of an elastomeric adhesive and a discontinuous phase of moisture-absorbing and swellable hydrocolloid particles. A convex adapter comprises: (1) an adapter ring formed of a soft shape-recoverable skin barrier material having a convex bodyside surface, a planar opposite surface, and a centrally-located stoma-receiving opening (21); (2) a removable release sheet (25) covering the opposite surface; and (3) a non-stretchable and removable cover film (24) covering the convex surface. The barrier material comprises a continuous phase of an elastomeric adhesive and a discontinuous phase of moisture-absorbing and swellable hydrocolloid particles. The removable cover film is transparent for revealing the adapter ring, and having a marginal portion extending outwardly beyond the periphery of the adapter ring.
Patent DK-1565207-T3 (DK)
Inventor: GEHRINGER WERNER
IPC: C07K14/76
Filed: 2003-11-25
Granted: 2006-08-14
Abstract: An albumin containing fraction having a reduced prekallikrein activator (PKA) content and a method of manufacturing same comprising the steps of: (a) reconstitution of paste V (Cohn fractionation), (b) performing a concentration step of the fraction obtained in step (a), (c) heating the fraction obtained in step (b) in a range of from 50° C. to 70° C. for a sufficient time to pasteurize the fraction, and (d) optionally filling of the obtained fraction for use.
Patent DK-1500687-T3 (DK)
Inventor: GILLI ALBERTO
IPC: C09D11/02
Filed: 2004-06-18
Granted: 2008-09-08
Abstract: The present invention relates to inks for silk-screen printing technique, as well as the corresponding printing technique, designed to bestow upon the reproduction obtained by means of the use of said inks on an appropriate substrate, preferably of a paper type, a particular feel, preferably a particular roughness or coarseness. In particular, the present invention relates to an ink for silk-screen printing of catalogues or advertising leaflets for products designed for decorative wall coatings that will reproduce also the feel of the final decoration applied on the wall substrate.
Patent DK-1639263-T3 (DK)
Inventor: NIELSEN ESBEN BRUN
IPC: A47B96/14
Filed: 2004-06-23
Granted: 2011-11-14
Abstract: A joint between an element (12) and an elongate rail (15) having an abutment face (17) abutting on the element. The rail is provided with a plurality of separate engagement pins (18) that protrude from the abutment face (17) at a mutual distance in relation to a longitudinal direction of the rail. The element (12) is provided with a longitudinally extending groove (10) into which the engagement pins (18) extend. Additionally, a method of manufacturing an elongate rail (15) for mounting on an element (12), which method comprises extrusion of a rail having a continuous, longitudinally extending protrusion that extends laterally in relation to a longitudinal direction of the rail, said protrusion being machined to the effect that separate engagement pins (18) are formed that have a mutual distance in the longitudinal direction of the rail (15).
Patent DK-1778833-T3 (DK)
Inventor: FRASER JOHN K
IPC: A61K35/28
Filed: 2004-07-01
Granted: 2011-06-27
Abstract: Cells present in adipose tissue are used to promote wound healing in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the regenerative cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in adipose tissue are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic benefit.
Patent DK-1637250-T3 (DK)
Inventor: HARTENBAUER LOTHAR
IPC: B21F27/12
Filed: 2005-08-04
Granted: 2009-04-14
Abstract: The machine includes a welding equipment for joining a spiral wire to several longitudinal wires. The welding equipment is attached to a radial adjustment mechanism (18) which is arranged on a radially adjustable carrier (11). The radial adjustment mechanism has its own drive unit (19) which is located outside of or on the radial adjustment mechanism. An independent claim is included for the continuous production of circular, non-circular, and polygonal reinforcement cages.
Patent DK-1698995-T3 (DK)
Inventor: NUEBLING RALF ULRICH
IPC: G06K7/10
Filed: 2005-12-24
Granted: 2008-05-13
Abstract: The device has an imaging optics comprising a deflecting lens (7) arranged on an optical axis in front of a opto receiver (3) and supported in a rotating axis by pivot arms. The lens attached to the pivot arms includes an optical component influencing a focal length of the imaging optics, so that an effective optical back focus and the focal length of the imaging optics are changeable, during rotation of pivot arms.
Patent DK-1729770-T3 (DK)
Inventor: ARKIN MICHELLE
IPC: F24S10/70
Filed: 2005-03-14
Granted: 2010-04-12
Abstract: The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2  to 100 mg/m 2 .
Patent DK-1781537-T3 (DK)
Inventor: JOERGENSEN KENT MOELSTED
IPC: B63C9/22
Filed: 2005-06-27
Granted: 2008-02-04
Abstract: The present invention relates to a container for storing an inflatable liferaft, the container including a bag adapted to contain a deflated liferaft and means for inflating the liferaft using an inflating gas, preferably CO<SUB>2 </SUB>or a mixture of gases, wherein the substantial part is CO<SUB>2</SUB>. The inflating means being connected to the liferaft, preferably being substantially contained inside the bag. The bag furthermore has means for measuring and/or monitoring at least the relative humidity (R.H.) and the CO<SUB>2</SUB>-content of the gas inside the bag.
Patent DK-1724878-T3 (DK)
Inventor: MEYER DAVID G
IPC: H01R4/18
Filed: 2006-05-11
Granted: 2009-11-23
Abstract: An electrical contact includes a crimping section (102) for securing a wire and a flute section (104) for receiving a pin. The flute section includes fixed engagement members (140) and a resilient cantilever member (150) that engages the pin within the flute section.
Patent DK-1871720-T3 (DK)
Inventor: LAUBACH BENNO
IPC: C04B22/14
Filed: 2006-04-07
Granted: 2014-01-20
Abstract: Production of a hydraulic binder consisting mainly of cement involves addition as a chromate reducer of iron (II) sulfate monohydrate (FeSO 4.H 2O), at least part of which is milled together with the cement clinker.
Patent DK-1976804-T3 (DK)
Inventor: NOVAK RICHARD
IPC: C02F1/78
Filed: 2007-09-28
Granted: 2010-03-22
Abstract: A system and method for the ozone treatment of wastewater is disclosed. The disclosed wastewater treatment system includes a high selectivity reactor coupled to an activated sludge treatment basin. The high selectivity reactor is adapted to receive a stream containing sludge diverted directly or indirectly from the activated sludge treatment basin. The disclosed wastewater treatment system and method is adapted to inject a chemical agent, such as ozone-enriched gas, into the diverted stream for treatment within the high selectivity reactor for purposes of sludge reduction, foam control, or bulking control. The treated stream is then returned to the activated sludge treatment basin.
Patent DK-2176144-T3 (DK)
Inventor: LUCCHI MARCO
IPC: B65G17/08
Filed: 2008-07-17
Granted: 2011-08-29
Abstract: A belt designed for improved cleanability achieved by large link distances thus reducing the number of gaps. The module design reduces the undesirable elasticity of the belt under load by having link pairs, formed by links on adjacent modules, that are moved as close together as possible leaving large open spaces between the link pairs.
Patent DK-2218638-T3 (DK)
Inventor: CHRISTOPHEL CLAUS-D
IPC: B63H23/24
Filed: 2009-02-16
Granted: 2012-07-16
Abstract: The system (1) has a drive shaft (3) comprising modular units that are formed from two propellers (2). Multiple electric drives (4) are arranged on the drive shaft. Generators (9) form second modular units as a power supply for the electric drives. A control unit forms third modular units for selectively activating and controlling the electric drives and the generators. The generators are arranged in a nose region of a ship. The electrical drives are arranged in a tail region of the ship. The electric drives are mounted on base plates.
Patent DK-2419104-T3 (DK)
Inventor: BEATTIE DAVID
IPC: A61P25/28
Filed: 2010-04-12
Granted: 2018-02-05
Abstract: The invention relates to the use of specific 5-HT4 receptor agonist compounds for the treatment of cognitive disorders, in particular, to the use of these compounds in combination with other agents, specifically acetylcholinesterase inhibitors, for the treatment of Alzheimer's disease and other cognitive disorders.
Patent DK-2427838-T3 (DK)
Inventor: SHRIVASTAVA SAURABH K
IPC: G06F17/50
Filed: 2010-05-06
Granted: 2013-12-09
Abstract: A system and method for providing a layout of equipment in a data center, the equipment including a plurality of equipment racks, and at least one rack-based cooling provider. In one aspect, the method includes receiving data regarding airflow consumption for each of the plurality of equipment racks and cooling capacity of the at least one cooling provider, determining a layout of the data center, displaying the layout of the data center. In the method determining a layout can include pairing each equipment rack of the plurality of equipment racks with another equipment rack of the plurality of equipment racks based on airflow consumption of each of the plurality of equipment racks to create a plurality of pairs of equipment racks, arranging the pairs of equipment racks to form a two-row cluster of equipment racks based on the airflow consumption value of the equipment racks.
Patent DK-2877166-T3 (DK)
Inventor: GUCKIAN KEVIN
IPC: C07D471/08
Filed: 2013-07-26
Granted: 2018-04-23
Abstract: Disclosed are bicyclic aryl compounds of formula (I), that can modulate the activity of the autotaxin (ATX) enzyme. This invention further relates to compounds that are ATX inhibitors, and methods of making and using such compounds in the treatment of demyelination due to injury or disease, as well as for treating proliferative disorders such as cancer.
Patent DK-2951290-T3 (DK)
Inventor: BHARTI KAPIL
IPC: C12N5/079
Filed: 2014-01-31
Granted: 2018-01-22
Abstract: High efficiency methods for producing retinal pigment epithelial cells from induced pluripotent stem cells (iPSCs) are disclosed herein. The iPSCs are produced from somatic cells, including retinal pigment epithelial (RPE) cells, such as fetal RPE stem cells. In some embodiments, the iPSC include a tyrosinase promoter operably linked to a marker. Methods are disclosed for using the RPE cells, such as for treatment. Methods for screening for agents that affect RPE differentiation are also disclosed.
Patent DK-2970853-T3 (DK)
Inventor: MYLES MATTHEW H
IPC: C12Q1/10
Filed: 2014-03-11
Granted: 2018-04-09
Abstract: Management of the health status of an animal colony using a plurality of blood collection cards and the analysis of dried blood from members of the colony that has been collected on the cards. Members of the colony may be removed from the colony as a result of the analysis.
Patent DK-0400531-T3 (DK)
Inventor: BASTIOLI CATIA
IPC: B29C48/08
Filed: 1990-05-28
Granted: 1997-07-21
Abstract: Biodegradable composition comprising destructured starch, a thermoplastic polymer and a high-boiling plasticiser in an amount from 0.05 to 100% of the weight of the starch, where in the starch is obtained by destructuring starch as it is without the addition of water.
Patent DK-0417607-T3 (DK)
Inventor: MOCHIDA EI
IPC: B01J19/28
Filed: 1990-09-04
Granted: 1993-10-04
Abstract: An apparatus (10) for reaction between a solid phase and a liquid phase of the present invention allows a tubular reaction vessel (50) accommodating the liquid phase that reacts with the solid phase bound to the inside surface of said reaction vessel to hold in the peripheral region of a rotating element (12) inclined with respect to the horizontal direction and also allows said tubular reaction vessel (50) to repeat a predetermined number of cycles, each consisting at least of the steps of rotating continuously said rotating element in the inclined state at a predetermined constant speed for a predetermined time and loading/unloading said reaction vessel for the rest time of the rotating element. Because of these features, the apparatus of the present invention makes possible to have a simple construction which can be easily handled and can continuously promote the reaction in a plurality of the reaction vessels under identical reaction conditions for identical reaction time at a series of time.
Patent DK-0433769-T3 (DK)
Inventor: PELTO-HUIKKO RAIMO
IPC: B66B1/04
Filed: 1990-12-05
Granted: 1995-05-29
Abstract: Control valve for a hydraulic elevator, provided with a speed regulating plug (2) which moves with the flow of the hydraulic fluid and whose position determines the flow of hydraulic fluid into the actuating cylinder of the elevator. At each end of the speed regulating plug, the valve is connected to a system 1 of hydraulic channels (1) in which the hydraulic fluid flows and which communicates with the main hydraulic circuit. Besides a throttle (9), an additional channel (10) is connected to the hydraulic channel system (1), said additional channel being provided with a flow resistance component comprising a capillary throttle (12). <IMAGE>
Patent DK-0383472-T3 (DK)
Inventor: CHANCE RONALD EUGENE
IPC: C07K/
Filed: 1990-02-06
Granted: 1996-05-06
Abstract: Analogs of human insulin modified at position 29 of the B chain thereof and, optionally, at other positions, have modified physico-chemical and pharmacokinetic properties and are useful in the treatment of hyperglycemia. The insulin analogs are of the formula <IMAGE> or a pharmaceutically acceptable salt thereof, wherein A21 is alanine, asparagine, aspartic acid, glutamine, glutamic acid, glycine, threonine, or serine; B1 is phenylalanine, aspartic acid, or is absent; B2 is valine or may be absent when B1 is absent; B3 is asparagine or aspartic acid; B9 is serine or aspartic acid; B10 is histidine or aspartic acid; B27 is threonine or is absent; B28 is any amino acid, B29 is L-proline, D-proline, D-hydroxyproline, L-hydroxyproline, L-(N-methyllysine), D-lysine, L-(N-methylarginine) or D-arginine; B30 is alanine, threonine or is absent; Z is -OH, -NH2, -OCH3, or -OCH2CH3; X is Arg, Arg-Arg, Lys, Lys-Lys, Arg-Lys, Lys-Arg, or is absent; and Y may be present only when X is present and, if present, is Glu or an amino acid sequence which comprises all or a portion of the sequence <IMAGE>  and which begins at the N-terminus Glu of such sequence; provided that when A21 is asparagine, B1 is phenylalanine, B2 is valine, B3 is asparagine, B9 is serine, B10 is histidine, B27 is threonine, B28 is lysine, B29 is L-proline, B30 is threonine, X is absent and Y is absent, then Z is -NH2, -OCH3 or -OCH2CH3.
Patent DK-0407028-T3 (DK)
Inventor: CLARK ANDREW REGINALD
IPC: A61M15/00
Filed: 1990-05-29
Granted: 1995-02-06
Abstract: A device for the administration by inhalation of a medicament in powdered form comprises a medicament reservoir (3) and metering means for dispensing a dose of medicament from the reservoir (3), characterized in that the reservoir (3) comprises a compacted body of powdered medicament (10) and the metering means includes means (11) for abrading the compacted body (10).
Patent DK-0489837-T3 (DK)
Inventor: WAYNER ELIZABETH
IPC: A61K38/39
Filed: 1990-08-31
Granted: 2004-03-01
Abstract: The present invention relates to a method for inhibiting the adhesion of one cell to another comprising interfering with the interaction between the extracellular matrix receptor and its ligand. The invention is based upon the discovery that the  alpha 4 beta 1 extracellular matrix receptor promotes adhesion of lymphocytes to endothelial cells via attachment to a defined peptide sequence. Prior to the present invention, the ligand of the  alpha 4 beta 1 receptor had not been identified, nor had the function of the  alpha 4 beta 1 receptor in lymphocyte attachment been known. By preventing the interaction between the  alpha 4 beta 1 receptor and its ligands using antibodies or defined peptide sequences, the present invention enables, for the first time, specific intervention in the migration of lymphocytes through the vascular endothelium and into tissues. The present invention, therefore, has particular clinical utility in suppression of the immune response, in various specific embodiments of the invention, the adherence of lymphocytes to endothelium may be inhibited systemically, or may, alternatively, be localized to particular tissues or circumscribed areas. Accordingly, the present invention provides for treatment of diseases involving autoimmune responses as well as other chronic or relapsing activations of the immune system, including allergy, asthma, and chronic inflammatory skin conditions.
Patent DK-0449082-T3 (DK)
Inventor: STEINHOFF JUN ALBERT DIPL-ING
IPC: F16L21/03
Filed: 1991-03-19
Granted: 1994-02-21
Abstract: The invention relates to a joint with a sleeve, especially for use in sewage construction, consisting of   - a sleeve of cured material (concrete, steel-reinforced concrete, synthetic resin or the like);   - a tip end of a pipe as an insertion part and - a sealing ring (6), consisting of elastomeric material, which is fixedly connected to the sleeve base by means of anchoring feet (15, 16) (integrated joint with sleeve) and extends into the level of the sleeve in order to seal the gap between the sleeve and the tip end of the connecting pipe.   The essential feature of the invention is that - the sealing ring (6) has a multi-row construction of channels (11, 12, 13, 14), (virtually) all the channels - when seen from row to row - being arranged offset with respect to one another. <IMAGE>
Patent DK-0454099-T3 (DK)
Inventor: VOLLBRECHT HEINZ-RUEDIGER DR
IPC: A23L15/00
Filed: 1991-04-24
Granted: 1993-11-22
Abstract: The procedure for removing cholesterol from egg yolk is carried out in such a manner that   1. a dilute egg yolk mixture is prepared by addition of an aqueous solution of ammonium carbonate or NaCl, 2. the dilute egg yolk mixture is mixed with a solid absorbent or complexing agent until the cholesterol is absorbed or complexed, respectively, and subsequently 3. the cholesterol-loaded solid absorbent or the cholesterol complex is separated from the egg yolk mixture and 4. ammonium carbonate or NaCl and, if necessary, water is then removed. c